It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...
The use of synthetic medical data (SMD) in AI development is on the rise, but its broader application is limited by the lack of a comprehensive evaluation framework. Here, Ghada Zamzmi and colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback